These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 3993535)

  • 1. Comparison of acebutolol with propranolol, quinidine, and placebo: results of three multicenter arrhythmia trials.
    Chandraratna PA
    Am Heart J; 1985 May; 109(5 Pt 2):1198-204. PubMed ID: 3993535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of acebutolol and propranolol therapy for ventricular arrhythmias.
    Platia EV; Berdoff R; Stone G; Reid PR
    J Clin Pharmacol; 1985 Mar; 25(2):130-7. PubMed ID: 2580866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sotalol versus class I and II antiarrhythmic agents.
    Hanyok JJ; MacNeil DJ
    Cardiovasc Drugs Ther; 1990 Jun; 4 Suppl 3():603-11. PubMed ID: 2275890
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acebutolol in essential hypertension: results of two multicenter studies against placebo and propranolol.
    Davidov M
    Am Heart J; 1985 May; 109(5 Pt 2):1158-67. PubMed ID: 2859780
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of the antiarrhythmic effects of acebutolol and propranolol in the treatment of ventricular arrhythmias.
    Glasser SP; Clark PI; Laddu AR
    Am J Cardiol; 1983 Nov; 52(8):992-5. PubMed ID: 6195911
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of acebutolol and propranolol for treatment of chronic ventricular arrhythmia: a placebo-controlled, double-blind, randomized crossover study.
    Singh SN; DiBianco R; Davidov ME; Gottdiener JS; Johnson WL; Laddu AR; Fletcher RD
    Circulation; 1982 Jun; 65(7):1356-64. PubMed ID: 6176357
    [No Abstract]   [Full Text] [Related]  

  • 7. Effect of acebutolol and propranolol on premature ventricular complexes.
    Aronow WS; Wong R; Plasencia G; Landa D; Turbow M
    Clin Pharmacol Ther; 1980 Jul; 28(1):28-31. PubMed ID: 6993085
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Variability of spontaneous and exercise-induced ventricular arrhythmias in the absence and presence of treatment with acebutolol or quinidine.
    Shapiro W; Park J; Koch GG
    Am J Cardiol; 1982 Feb; 49(2):445-54. PubMed ID: 6174041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acebutolol therapy for ventricular arrhythmia. A randomized placebo-controlled double-blind multicenter study.
    De Soyza N; Shapiro W; Chandraratna PA; Aronow WS; Laddu AR; Thompson CH
    Circulation; 1982 Jun; 65(6):1129-33. PubMed ID: 7042111
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduction of ventricular ectopic beats with oral acebutolol: a double-blind, randomized crossover study.
    Lui HK; Lee G; Dhurandhar R; Hungate EJ; Laddu A; Dietrich P; Mason DT
    Am Heart J; 1983 May; 105(5):722-6. PubMed ID: 6846115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison of the experimental anti-arrhythmic properties of acebutolol (M and B 17,803), propranolol and practolol.
    Basil B; Jordan R; Loveless AH; Maxwell DR
    Br J Pharmacol; 1974 Mar; 50(3):323-33. PubMed ID: 4850183
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acebutolol for premature ventricular contractions: short- and long-term effects.
    de Soyza N
    Am Heart J; 1985 May; 109(5 Pt 2):1205-9. PubMed ID: 3993536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Double blind cross-over clinical trial of acebutolol and propranolol in angina pectoris.
    Pandhi P; Sethi V; Sharma BK; Wahi PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):598-600. PubMed ID: 3908331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of age and race on clinical response to acebutolol in essential hypertension.
    Boyles PW
    Am Heart J; 1985 May; 109(5 Pt 2):1184-92. PubMed ID: 2859783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Double-blind cross-over clinical trial of acebutolol and propranolol in mild to moderate essential hypertension.
    Pandhi P; Sethi V; Sharma BK; Wahl PL; Sharma PL
    Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):606-8. PubMed ID: 3908332
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of mexiletine in chronic ventricular arrhythmias compared with quinidine: a single-blind, randomized trial.
    Singh JB; Rasul AM; Shah A; Adams E; Flessas A; Kocot SL
    Am J Cardiol; 1984 Jan; 53(1):84-7. PubMed ID: 6362388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of acebutolol and propranolol in essential hypertension.
    Wahl J; Turlapaty P; Singh BN
    Am Heart J; 1985 Feb; 109(2):313-21. PubMed ID: 3880995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of propafenone on ventricular arrhythmias: double-blind, parallel, randomized, placebo-controlled dose-ranging study.
    Singh BN; Kaplinsky E; Kirsten E; Guerrero J
    Am Heart J; 1988 Dec; 116(6 Pt 1):1542-51. PubMed ID: 3057844
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative effects of oral acebutolol and propranolol at rest and during exercise in ischemic heart disease: double-blind placebo crossover study utilizing radionuclide ventriculography.
    Kaul S; Hecht HS; Seidman R; Hopkins J; Singh BN
    Am Heart J; 1984 Sep; 108(3 Pt 1):469-74. PubMed ID: 6382987
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of the antianginal efficacy of acebutolol and propranolol. A multicenter, randomized, double-blind placebo-controlled study.
    DiBianco R; Singh SN; Shah PM; Newton GC; Miller RR; Nahormek P; Costello RB; Laddu AR; Gottdiener JS; Fletcher RD
    Circulation; 1982 Jun; 65(6):1119-28. PubMed ID: 6804109
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.